INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.420
-0.070 (-4.70%)
At close: Jun 26, 2026, 4:00 PM EDT
1.487
+0.067 (4.73%)
After-hours: Jun 26, 2026, 7:24 PM EDT
INmune Bio Employees
INmune Bio had 21 employees as of December 31, 2025. The number of employees decreased by 1 or -4.55% compared to the previous year.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,981,000
Market Cap
37.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Senti Biosciences Holdings | 39 |
| Daré Bioscience | 24 |
| ABVC BioPharma | 19 |
| RenovoRx | 17 |
| Apollomics | 14 |
| Nutriband | 13 |
| Actuate Therapeutics | 12 |
INMB News
- 3 days ago - INmune Bio receives MHRA approval for Ebstrocel pediatric investigation plan - TheFly
- 3 days ago - INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ - GlobeNewsWire
- 4 days ago - INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting - TheFly
- 4 days ago - INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB - GlobeNewsWire
- 11 days ago - INmune Bio Transcript: AGM 2026 - Transcripts
- 25 days ago - INmune Bio reports positive MRI data in Phase 2 Alzheimer’s trial - TheFly
- 25 days ago - INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial - GlobeNewsWire
- 26 days ago - INmune Bio Slides: Corporate presentation - Filings